Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The content on this page has been written and fact-checked in accordance with our Editorial Policy
Stable and Inert- Optimized immobilization manufacturing method provides leach-resistant covalent bonds, resulting in low nonspecific binding and enabling multiple uses without compromising the yield
12 hours | Primary site of action: extracellular matrix, gene expression | Key receptors: TGF-beta, MMP/TIMP | Research focus: skin regeneration, anti-aging, collagen | Endogenous: yes (plasma component) | Gene modulation: over 4,000 genes BPC-157 Half-life: approx
The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
US$ 28.38
US$ 28.60
US$ 28.25
US$ 22.88
US$ 23.50
US$ 23.10
US$ 23.36
